Patents by Inventor Colin Jack Theobald

Colin Jack Theobald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS
    Publication number: 20120283438
    Abstract: The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.
    Type: Application
    Filed: July 18, 2012
    Publication date: November 8, 2012
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: Linos LAZARIDES, Stephen Allan SMITH, Richard STOCKER, Colin Jack THEOBALD
  • COMPOUNDS
    Publication number: 20110269781
    Abstract: The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.
    Type: Application
    Filed: June 7, 2011
    Publication date: November 3, 2011
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: Linos Lazarides, Stephen Allan Smith, Richard Stocker, Colin Jack Theobald
  • Compounds
    Patent number: 7977344
    Abstract: The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: July 12, 2011
    Assignee: GlaxoSmithKline LLC
    Inventors: Linos Lazarides, Stephen Allan Smith, Richard Stocker, Colin Jack Theobald
  • PURINE DERIVATIVES AS IMMUNOMODULATORS
    Publication number: 20100120799
    Abstract: Compounds of formula (I): wherein R1 is C1-8alkylamino, C1-8alkoxy, C3-7cycloalkylC1-6alkylamino, C3-7cycloalkylC1-6alkoxy, C1-3alkoxyC2-3alkoxy, or Hetb-C1-3alkoxy; Hetb is a 5- or 6-membered saturated aliphatic heterocycle containing one oxygen atom; R2 is —(CH2)n-Het; n is an integer having a value of 1 to 4; Het is a 5- or 6-membered saturated aliphatic heterocycle containing one oxygen heteroatom, which heterocycle may be substituted by one or two C1-4alkyl groups, and salts and solvates thereof, are inducers of human interferon and may be useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.
    Type: Application
    Filed: February 15, 2008
    Publication date: May 13, 2010
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Linos Lazarides, Stephen Allan Smith, Richard Stocker, Colin Jack Theobald
  • Compounds
    Publication number: 20090131458
    Abstract: The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.
    Type: Application
    Filed: February 15, 2008
    Publication date: May 21, 2009
    Applicant: SmithKline Beecham Corporation
    Inventors: Linos Lazarides, Stephen Allan Smith, Richard Stocker, Colin Jack Theobald